Lovastatin in the Treatment of Multifactorial Hyperlipidemia Associated With Proteinuria

BMDP Statistical Software 1981.

1984 • 5,347 citations

High density lipoprotein as a protective factor against coronary heart disease

1977 • 5,019 citations

The Lipid Research Clinics Coronary Primary Prevention Trial Results

1984 • 2,673 citations

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

1975 • 2,653 citations

Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

1987 • 1,651 citations

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

1980 • 1,607 citations

The Lipid Research Clinics Coronary Primary Prevention Trial Results

1984 • 1,373 citations

Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.

1980 • 1,195 citations

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project

1978 • 951 citations

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

1976 • 926 citations

ACRODERMATITIS ENTEROPATHICA: A LETHAL INHERITED HUMAN ZINC-DEFICIENCY DISORDER

1974 • 633 citations

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

1983 • 562 citations

Risk Factors in Coronary Heart Disease: An Evaluation of Several Serum Lipids as Predictors of Coronary Heart Disease: The Framingham Study

1964 • 522 citations

Diet, Lipoproteins, and the Progression of Coronary Atherosclerosis

1985 • 494 citations

Efficacy and long-term adverse effect pattern of lovastatin

1988 • 338 citations

Probability of Middle-Aged Men Developing Coronary Heart Disease in Five Years

1972 • 262 citations

Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia

1981 • 262 citations

The Hyperlipidemia of the Nephrotic Syndrome

1985 • 218 citations

Effect of Diet on Serum Lipoproteins in a Population with a High Risk of Coronary Heart Disease

1982 • 215 citations

Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia

1987 • 215 citations

Diseases of the lungs.

1948 • 211 citations

Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia.

1985 • 210 citations

Experimental reconstruction of metabolic pattern of lipid nephrosis: key role of hepatic protein synthesis in hyperlipemia.

1960 • 210 citations

Preclinical evaluation of lovastatin

1988 • 203 citations

Dyslipoproteinemia in systemic lupus erythematosus

1987 • 190 citations

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

1984 • 176 citations

Therapeutic response to lovasatain (Mevinolin) in nonfamilial hypercholesterolemia - A Multicenter study

1986 • 175 citations

Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial Hypercholesterolemia

1986 • 160 citations

High-density lipoproteins in myocardial infarction survivors

1978 • 146 citations

Hepatic Secretion of Lipoproteins in the Rat and the Effect of Experimental Nephrosis

1979 • 141 citations

Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolism

1988 • 129 citations

COMPLICATIONS DURING CLOFIBRATE TREATMENT OF NEPHROTIC-SYNDROME HYPERLIPOPROTEINÆMIA

1972 • 128 citations

ISCHIEMIC HEART-DISEASE AS A COMPLICATION OF NEPHROTIC SYNDROME

1969 • 119 citations

CUSUM CHARTS

1974 • 117 citations

Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome

1977 • 113 citations

The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: A prospective study

1984 • 109 citations

Status of the coronary arteries in the nephrotic syndrome

1977 • 98 citations

The Nephrotic Syndrome and Ischaemic Heart Disease

1981 • 98 citations

Albumin synthesis, albuminuria and hyperlipemia in nephrotic patients

1987 • 98 citations

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia

1986 • 86 citations

Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome

1968 • 85 citations

Studies on the metabolism of the serum proteins and lipids in a patient with analbuminemia

1964 • 75 citations

Lipoproteins in experimental nephrosis: Plasma levels and composition

1979 • 70 citations

Lipid and apolipoprotein levels in patients with nephrotic syndrome

1981 • 67 citations

INCREASED INCIDENCE OF CORONARY HEART DISEASE ASSOCIATED WITH COMBINED ELEVATION OF SERUM TRIGLYCERIDE AND CHOLESTEROL CONCENTRATIONS IN THE NEPHROTIC SYNDROME IN MAN

1974 • 59 citations

Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?

1981 • 59 citations

Lipoprotein profiles in adult nephrotics.

1975 • 55 citations

Plasma Triglyceride Metabolism in the Adult Nephrotic Syndrome

1971 • 54 citations

METABOLIC CHANNELING IN EXPERIMENTAL NEPHROSIS

1958 • 50 citations

Treatment of the Hyperlipidemia of the Nephrotic Syndrome: A Controlled Trial

1986 • 50 citations

HYPERLIPOPROTEINÆMIAS IN NEPHROTIC SYNDROME

1971 • 39 citations

The role of circulating mevalonate in nephrotic hypercholesterolemia in the rat.

1990 • 33 citations

METABOLIC CHANNELING IN EXPERIMENTAL NEPHROSIS

1958 • 32 citations

Origin of hypercholesterolemia in chronic experimental nephrotic syndrome

1977 • 27 citations

DRUGS AND THE KIDNEY*

1965 • 27 citations

Experimental nephrotic syndrome induced in the rat by puromycin aminonucleoside: Hepatic synthesis of neutral lipids and phospholipids from³H‐water and³H‐palmitate

1980 • 24 citations

Lipogenesis in aminonucleoside-induced nephrotic syndrome

1974 • 21 citations

Plasma Lipoprotein Lipase in Children with Idiopathic Nephrotic Syndrome

1969 • 20 citations

Drugs Affecting Kidney Function and Metabolism

1973 • 18 citations

Increased hepatic cholesterol production due to liver hypertrophy in rat experimental nephrosis

1982 • 17 citations

Hypolipidæmic Action of Gemfibrozil in Adult Nephrotics

1976 • 12 citations

<i>In vivo </i>Studies of the Metabolism of Mevalonic Acid in Nephrotic Rats

1972 • 7 citations

Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.

1974 • 6 citations

Low Density Lipoprotein Peptide Metabolism in the Nephrotic Syndrome

1970 • 3 citations

The Impact of Analbuminemia on Lipid Transport and Lipoproteins

1983 • 1 citations